Nova Leap Health Corp. Posts Q1 2026 Results

The most recent release (May 7, 2026) reports Q1 2026 financials alongside the closing of a strategic acquisition. - Q1 revenue of $7.85 M, up 10.7 % year-over-year; Adjusted EBITDA $461 k, up 59.6 %; net income swung to a profit of $324 k from a prior-year loss. - Trailing-twelve-month (TTM) revenue hit a record $32.2 M and TTM Adjusted EBITDA a record $2.2 M. - On May 1, the company completed the CAD $3.5 M acquisition of Parkwood Home Care Limited (Nova Scotia) through its Earth Angels subsidiary. Parkwood adds unaudited FY2025 revenues of ~$3.8 M and Adjusted EBITDA ~$785 k. - Post‑acquisition, cash stands at $1.6 M, with full access to a $1.08 M revolver and $3.05 M of remaining acquisition credit. Total debt is $1.96 M, a modest 0.88× TTM EBITDA.

The news is incrementally positive: revenue and profitability continue to trend upward, and the Parkwood acquisition densifies the Nova Scotia footprint with minimal leverage. However, the market had already absorbed the May 1 acquisition announcement; the Q1 release simply confirms its terms and adds a quarter of organic growth that aligns with the trajectory signaled in the 2025 year-end letter. No materially new information that would re‑rate the stock dramatically. For a risk‑averse analyst, this is a “Routine – Positive” event – steady execution, but nothing game‑changing.

Nova Leap Health Corp. provides home‑focused community care across the U.S. and Canada. Its core is traditional home care, but the strategy is evolving into a four‑pillar continuum: Home Care, Care Management, Palliative Care, and a planned Private Nursing line (FY 2027). The flagship Canadian subsidiary is Earth Angels Home Care, which anchors the Nova Scotia market and now includes the new Palliative Care division and the Parkwood acquisition. In the U.S., a Care Management division was launched in late 2025, initially targeting Massachusetts.